At the news
? BEARISHIMPACT 7/10 424B5 filed Apr 13, 2026 at 16:36 ET
Revolution Medicines is raising $250 million through a convertible senior notes offering, with a concurrent $750 million common stock offering. The notes are unsecured and rank below existing secured debt, increasing financial risk.
- Company is offering $250 million in convertible senior notes due 2033
- Concurrent common stock offering of $750 million
- Notes are senior unsecured obligations, structurally subordinated to subsidiary liabilities
- Company had $268.4 million in royalty sale liabilities as of December 31, 2025
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access